✨ Your Portfolio is fetched and updated from zerodha.
Nano Hospitals
Market Cap
₹236 Cr.
P/E
64.72

Key Ratios

Market cap
Market cap
236 Cr
PE
PE
64.72
Prom Holding
Prom Holding
61.44 %
ROE (%)
ROE (%)
6.80
ROCE (%)
ROCE (%)
9.10
Div Yield (%)
Div Yield (%)
-
Sales
Sales
46.03 Cr
OPM (%)
OPM (%)
0.13 %
Debt to Equity
Debt to Equity
-

About

Nephro Care India, established in 2014, is a comprehensive medical service provider for renal … Read more
Low
100
52W Range
High
274
  • Nephro Care India
  • Star Imaging & Path
  • Lotus Eye Hospital

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

9 Yes

Positive for this company

1 Neutral

Neutral for this company

4 No

Negative for this company

3 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up

Peer Comparison

FAQs on Nephro Care India Ltd. Business

Nephro Care India was incorporatedin the year 2014 with an object of providing comprehensive medical services for renal patients. The company is a one stop treatment centre based in Kolkata that offers a wide range of clinical and lifestyle solutions and services and renal insufficiency treatment to patients. The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness.

Nephro Care India major competitors are Star Imaging & Path, Lotus Eye Hospital, Unihealth Hospitals, Asarfi Hospital Ltd., Aashka Hospitals, Vaidya Sane Ayur Lab, Maitreya Medicare.
Market Cap of Nephro Care India is ₹236 Crs.
While the median market cap of its peers are ₹249 Crs.

Nephro Care India seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material